Linking therapeutically active molecules to specific antibodies can help to pilot them to their designated targets and minimize side effects -- especially when treating tumors. Scientists have now described novel conjugates made from antibodies and a kinesin spindle protein inhibitor. Changing the linker between the two components allows for tuning the activity of this cytostatic drug, which is effective against a broad palette of cancers.
from Top Health News -- ScienceDaily https://ift.tt/2yHugYJ
Subscribe to:
Post Comments (Atom)
-
from Yahoo News - Latest News & Headlines https://ift.tt/3F3zLk8
-
Three treaties between the US and Hong Kong were suspended, the latest move to pressure China. from Yahoo News - Latest News & Headl...
-
At least 22 people were killed and 171 others injured on Sunday when one of Taiwan’s newer, faster trains derailed on a curve along a popula...
No comments:
Post a Comment